Researchers at the Icahn School of Medicine at Mount Sinai have identified a shared molecular trait in glioblastoma, an aggressive brain cancer in adults. It resembles one used by immature cells during brain development and may reveal a target for future treatments.
❓ Unknown
A shared molecular weakness in glioblastoma tumor cells may offer a new treatment target
Just now
November 19, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
This article is not about Iran. Researchers at Mount Sinai identified a molecular weakness in glioblastoma brain cancer that could lead to new treatments. This medical research has no direct relevance to Iranian affairs.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Davoud Rokhbin Executed for Murder in Kashan Prison
Just now •
Ali Mokhtari Executed for Rape in Shahre Kord
7 min ago •
Supreme Leader Khamenei Leads Memorial Service for Grand Ayatollah Vahid Khorasani at Razavi Shrine
8 min ago •
Why using a chatbot as your lawyer is a risky move—and ties up our court…
8 min ago •